Ethics

The online based data registry is used for collecting observational data of routine TDM in all cases of pharmacotherapy in children and adolescents.
During the feasibility phase the evaluation focuses on atypical antipsychotics and modern antide¬pressants, especially SSRIs.
Every patient treated with these psychotropic drugs should be enrolled.
Ethical committees approved the study design stating TDM as a part of clinical routine procedures in order to optimize individual dosage finding and prevention of side effects.
For data safety reasons informed consent on data collection and data analysis is obtained from patients and parents.
Every new centre has to contact the local ethics committee to obtain a positive vote in order to be able to participate in the society.

Of course we provide interested parties with the necessary documents and guarantee our support

Contact & Imprint

Network secretariat:

Competence network "TDM KJP e.V."
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
University Hospital Würzburg
Margarete-Höppel-Platz 1
97080 Würzburg

Tel.: (+49) 0731-500-61710
Email: Contact

Kontakt


Info

Pharmakovigilanz bei Patienten im Kindes- und Jugendalter

Info-Flyer TDM KJP e.V.

Chairs of the association:

PD Dr. Stefanie Fekete

1st Chair:
PD Dr. Stefanie Fekete
Address: see network secretariat



2nd Chair:
Prof. Dr. Andreas Karwautz

Further board members:

Prof. Christian Fleischhaker

Treasurer:
Prof. Christian Fleischhaker

Dr. med. Karin Egberts

Secretary:
Dr. med. Karin Egberts
Center of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
University Hospital Würzburg
Address:
Margarete-Höppel-Platz 1 (formerly Füchsleinstr. 15)
97080 Würzburg